{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T06:47:01Z","timestamp":1778568421895,"version":"3.51.4"},"reference-count":88,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["SPG\/2021\/003904"],"award-info":[{"award-number":["SPG\/2021\/003904"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Journal of Tuberculosis"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.ijtb.2023.12.002","type":"journal-article","created":{"date-parts":[[2023,12,23]],"date-time":"2023-12-23T16:21:24Z","timestamp":1703348484000},"page":"453-459","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Tuberculosis vaccine - A timely analysis of the drawbacks for the development of novel vaccines"],"prefix":"10.1016","volume":"71","author":[{"given":"Dr Sivakamavalli","family":"Jeyachandran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yashika","family":"Pusam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijtb.2023.12.002_bib1","series-title":"Global Tuberculosis Report","author":"Who","year":"2020"},{"key":"10.1016\/j.ijtb.2023.12.002_bib2","series-title":"Tuberculosis Is a Fatal Disease Among Some Developing Countries of the World","first-page":"18","author":"Mohajan","year":"2014"},{"issue":"1","key":"10.1016\/j.ijtb.2023.12.002_bib82","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.mjafi.2018.12.013","article-title":"Current trends in tuberculosis vaccine","volume":"75","author":"Soundarya","year":"2019","journal-title":"Med J Armed Forces India"},{"issue":"4","key":"10.1016\/j.ijtb.2023.12.002_bib83","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines8040586","article-title":"An overview of the development of new vaccines for tuberculosis","volume":"8","author":"Whitlow","year":"2020","journal-title":"Vaccines"},{"issue":"5","key":"10.1016\/j.ijtb.2023.12.002_bib84","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1586\/14760584.2014.905746","article-title":"The BCG replacement vaccine VPM1002: from drawing board to clinical trial","volume":"13","author":"Kaufmann","year":"2014","journal-title":"Expet Rev Vaccine"},{"key":"10.1016\/j.ijtb.2023.12.002_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108791","article-title":"A century of attempts to develop an effective tuberculosis vaccine: why they failed?","volume":"109","author":"Soleimanpour","year":"2022","journal-title":"Int Immunopharm"},{"issue":"1 & 2","key":"10.1016\/j.ijtb.2023.12.002_bib86","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4103\/ijmr.IJMR_1563_20","article-title":"Will bacille Calmette-Guerin immunization arrest the COVID-19 pandemic?","volume":"152","author":"Ehtesham","year":"2020","journal-title":"Indian J Med Res"},{"issue":"Pt A","key":"10.1016\/j.ijtb.2023.12.002_bib87","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ijbiomac.2018.08.037","article-title":"Novel vaccine candidates against Mycobacterium tuberculosis","volume":"120","author":"Khoshnood","year":"2018","journal-title":"Int J Biol Macromol"},{"issue":"8","key":"10.1016\/j.ijtb.2023.12.002_bib88","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1080\/21645515.2021.1885280","article-title":"A review of the BCG vaccine and other approaches toward tuberculosis eradication","volume":"17","author":"Cho","year":"2021","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.ijtb.2023.12.002_bib89","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.micpath.2017.08.040","article-title":"Antigen 85 complex as a powerful Mycobacterium tuberculosis immunogene: biology, immune-pathogenicity, applications in diagnosis, and vaccine design","volume":"112","author":"Karbalaei Zadeh Babaki","year":"2017","journal-title":"Microb Pathog"},{"issue":"2","key":"10.1016\/j.ijtb.2023.12.002_bib3","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2174\/157489111796064524","volume":"6","author":"Martins","year":"2011","journal-title":"Recent Pat Anti-Infect Drug Discov"},{"key":"10.1016\/j.ijtb.2023.12.002_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/ITT.S202006","article-title":"Bacillus calmette-gu\u00e9rin (BCG) therapy for bladder cancer: an update","volume":"9","author":"Guallar-Garrido","year":"2020","journal-title":"ImmunoTargets Ther"},{"key":"10.1016\/j.ijtb.2023.12.002_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2020.101431","article-title":"Key recent advances in TB vaccine development and understanding of protective immune responses against Mycobacterium tuberculosis","volume":"50","author":"Scriba","year":"2020","journal-title":"Semin Immunol"},{"key":"10.1016\/j.ijtb.2023.12.002_bib6","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1146\/annurev-immunol-032712-095939","article-title":"The immune response in tuberculosis","volume":"31","author":"O'Garra","year":"2013","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.ijtb.2023.12.002_bib7","volume":"2011","author":"Meraviglia","year":"2011"},{"issue":"3","key":"10.1016\/j.ijtb.2023.12.002_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2020.151951","article-title":"Natural and trained innate immunity against Mycobacterium tuberculosis","volume":"225","author":"Ferluga","year":"2020","journal-title":"Immunobiology"},{"key":"10.1016\/j.ijtb.2023.12.002_bib9","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/s12913-016-1545-9","article-title":"Coping with tuberculosis and directly observed treatment: a qualitative study among patients from South India","volume":"16","author":"Yellappa","year":"2016","journal-title":"BMC Health Serv Res"},{"issue":"5","key":"10.1016\/j.ijtb.2023.12.002_bib10","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1586\/erv.11.28","article-title":"Tuberculosis vaccines in clinical trials","volume":"10","author":"Rowland","year":"2011","journal-title":"Expet Rev Vaccine"},{"issue":"9","key":"10.1016\/j.ijtb.2023.12.002_bib11","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3349\/ymj.2020.61.9.789","article-title":"Diagnostic potential of a PPE protein derived from Mycobacterium tuberculosis beijing\/K strain","volume":"61","author":"Kim","year":"2020","journal-title":"Yonsei Med J"},{"issue":"1","key":"10.1016\/j.ijtb.2023.12.002_bib12","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1183\/13993003.00424-2016","article-title":"Digital health for the End TB Strategy: developing priority products and making them work","volume":"48","author":"Falzon","year":"2016","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.ijtb.2023.12.002_bib13","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.immuni.2008.09.017","article-title":"Regulation of hierarchical clustering and activation of innate immune cells by dendritic cells","volume":"29","author":"Kang","year":"2008","journal-title":"Immunity"},{"issue":"21","key":"10.1016\/j.ijtb.2023.12.002_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111398","article-title":"Nod-like receptors: critical intracellular sensors for host protection and cell death in microbial and parasitic infections","volume":"22","author":"Babamale","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ijtb.2023.12.002_bib15","volume":"2019","author":"Krakauer","year":"2019"},{"issue":"6","key":"10.1016\/j.ijtb.2023.12.002_bib16","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s00281-018-0710-0","article-title":"Macrophage-microbe interaction: lessons learned from the pathogen Mycobacterium tuberculosis","volume":"40","author":"BoseDasgupta","year":"2018","journal-title":"Semin Immunopathol"},{"issue":"4","key":"10.1016\/j.ijtb.2023.12.002_bib17","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/nrmicro2321","article-title":"Regulation of antigen presentation by Mycobacterium tuberculosis: a role for Toll-like receptors","volume":"8","author":"Harding","year":"2010","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ijtb.2023.12.002_bib18","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3389\/fimmu.2017.00967","article-title":"Memory of natural killer cells: a new chance against Mycobacterium tuberculosis?","volume":"8","author":"Chore\u00f1o Parra","year":"2017","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.ijtb.2023.12.002_bib19","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/joim.12449","article-title":"Trained immunity: a new avenue for tuberculosis vaccine development","volume":"279","author":"Lerm","year":"2016","journal-title":"J Intern Med"},{"key":"10.1016\/j.ijtb.2023.12.002_bib20","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.3389\/fimmu.2017.01437","article-title":"The equivocal role of th17 cells and neutrophils on immunopathogenesis of leishmaniasis","volume":"8","author":"Gon\u00e7alves-de-Albuquerque","year":"2017","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.ijtb.2023.12.002_bib21","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nri3174","article-title":"Targeting natural killer cells and natural killer T cells in cancer","volume":"12","author":"Vivier","year":"2012","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"10.1016\/j.ijtb.2023.12.002_bib22","doi-asserted-by":"crossref","first-page":"739","DOI":"10.4103\/0378-6323.120719","article-title":"New insights in the pathogenesis of type 1 and type 2 lepra reaction","volume":"79","author":"Pandhi","year":"2013","journal-title":"Indian J Dermatol, Venereol Leprol"},{"issue":"4","key":"10.1016\/j.ijtb.2023.12.002_bib23","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1189\/jlb.4MR0217-048RR","article-title":"Granulocytes as modulators of dendritic cell function","volume":"102","author":"Breedveld","year":"2017","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.ijtb.2023.12.002_bib24","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12950-016-0145-0","article-title":"Riboflavin along with antibiotics balances reactive oxygen species and inflammatory cytokines and controls Staphylococcus aureus infection by boosting murine macrophage function and regulates inflammation","volume":"13","author":"Dey","year":"2016","journal-title":"J Inflamm"},{"issue":"5","key":"10.1016\/j.ijtb.2023.12.002_bib25","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s12026-020-09149-1","article-title":"The role of Th17 cells in psoriasis","volume":"68","author":"Li","year":"2020","journal-title":"Immunol Res"},{"issue":"2","key":"10.1016\/j.ijtb.2023.12.002_bib26","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1365-2567.2008.03017.x","article-title":"Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens","volume":"126","author":"Curtis","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.ijtb.2023.12.002_bib27","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3389\/fimmu.2014.00180","article-title":"Functional signatures of human CD4 and CD8 T cell responses to Mycobacterium tuberculosis","volume":"5","author":"Prezzemolo","year":"2014","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.ijtb.2023.12.002_bib28","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/eji.201445193","article-title":"Human CD8 T lymphocytes recognize Mycobacterium tuberculosis antigens presented by HLA-E during active tuberculosis and express type 2 cytokines","volume":"45","author":"Caccamo","year":"2015","journal-title":"Eur J Immunol"},{"issue":"4","key":"10.1016\/j.ijtb.2023.12.002_bib29","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1046\/j.1440-1711.2000.00936.x","article-title":"Role of CD8 T cells in mycobacterial infections","volume":"78","author":"Smith","year":"2000","journal-title":"Immunol Cell Biol"},{"issue":"1","key":"10.1016\/j.ijtb.2023.12.002_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2020.100187","article-title":"Pulmonary MTBVAC vaccination induces immune signatures previously correlated with prevention of tuberculosis infection","volume":"2","author":"Dijkman","year":"2021","journal-title":"Cell reports. Medicine"},{"issue":"3","key":"10.1016\/j.ijtb.2023.12.002_bib31","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/eji.200839148","article-title":"How B cells shape the immune response against Mycobacterium tuberculosis","volume":"39","author":"Maglione","year":"2009","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.ijtb.2023.12.002_bib32","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/978-1-4614-6111-1_8","article-title":"Antigen-specific CD8(+) T cells and protective immunity to tuberculosis","volume":"783","author":"Behar","year":"2013","journal-title":"Adv Exp Med Biol"},{"issue":"9","key":"10.1016\/j.ijtb.2023.12.002_bib33","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/79631","article-title":"Is the development of a new tuberculosis vaccine possible?","volume":"6","author":"Kaufmann","year":"2000","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.ijtb.2023.12.002_bib34","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.tube.2011.07.005","article-title":"Mycobacterium tuberculosis Beijing genotype: a template for success","volume":"91","author":"Hanekom","year":"2011","journal-title":"Tuberculosis"},{"issue":"7","key":"10.1016\/j.ijtb.2023.12.002_bib35","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1128\/IAI.01999-06","article-title":"Lack of immune responses to Mycobacterium tuberculosis DosR regulon proteins following Mycobacterium bovis BCG vaccination","volume":"75","author":"Lin","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.ijtb.2023.12.002_bib36","first-page":"g4643","article-title":"Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis","volume":"349","author":"Roy","year":"2014","journal-title":"BMJ (Clinical Research Ed."},{"issue":"12","key":"10.1016\/j.ijtb.2023.12.002_bib37","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1136\/thx.2010.140186","article-title":"Protective effect of BCG vaccination in a nursery outbreak in 2009: time to reconsider the vaccination threshold?","volume":"65","author":"Eriksen","year":"2010","journal-title":"Thorax"},{"key":"10.1016\/j.ijtb.2023.12.002_bib38","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.3389\/fimmu.2018.02869","article-title":"Non-specific effects of vaccines illustrated through the BCG example: from observations to demonstrations","volume":"9","author":"Uthayakumar","year":"2018","journal-title":"Front Immunol"},{"issue":"52","key":"10.1016\/j.ijtb.2023.12.002_bib39","doi-asserted-by":"crossref","first-page":"8861","DOI":"10.1016\/j.vaccine.2007.10.025","article-title":"The effect of tuberculin skin test and BCG vaccination on the expansion of PPD-specific IFN-gamma producing cells ex vivo","volume":"25","author":"Ota","year":"2007","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.ijtb.2023.12.002_bib40","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1021\/nl500677j","article-title":"Virus-encapsulated DNA origami nanostructures for cellular delivery","volume":"14","author":"Mikkil\u00e4","year":"2014","journal-title":"Nano Lett"},{"issue":"3","key":"10.1016\/j.ijtb.2023.12.002_bib41","first-page":"286","article-title":"The relationship between malnutrition and tuberculosis: evidence from studies in humans and experimental animals","volume":"8","author":"Cegielski","year":"2004","journal-title":"Int J Tubercul Lung Dis"},{"key":"10.1016\/j.ijtb.2023.12.002_bib42","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3389\/fimmu.2013.00098","article-title":"Modeling the Mycobacterium tuberculosis granuloma - the critical battlefield in host immunity and disease","volume":"4","author":"Guirado","year":"2013","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.ijtb.2023.12.002_bib43","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S1473-3099(09)70330-5","article-title":"Possible underlying mechanisms for successful emergence of the Mycobacterium tuberculosis Beijing genotype strains","volume":"10","author":"Parwati","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"10.1016\/j.ijtb.2023.12.002_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070514","article-title":"Secreted acid phosphatase (SapM) of Mycobacterium tuberculosis is indispensable for arresting phagosomal maturation and growth of the pathogen in Guinea pig tissues","volume":"8","author":"Puri","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.ijtb.2023.12.002_bib45","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S1473-3099(13)70015-X","article-title":"Tuberculosis comorbidity with communicable and non- communicable diseases: integrating health services and control efforts","volume":"13","author":"Marais","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijtb.2023.12.002_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.invent.2021.100373","article-title":"Efficacy of digital health interventions in youth with chronic medical conditions: a meta-analysis","volume":"24","author":"Domhardt","year":"2021","journal-title":"Internet interventions : the application of information technology in mental and behavioural health"},{"key":"10.1016\/j.ijtb.2023.12.002_bib47","series-title":"Roadmap for Childhood Tuberculosis: Towards Zero Deaths","author":"Health","year":"2013"},{"issue":"Suppl 1","key":"10.1016\/j.ijtb.2023.12.002_bib48","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/dom.14290","article-title":"Obesity as a multisystem disease: trends in obesity rates and obesity-related complications","volume":"23","author":"Sarma","year":"2021","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.ijtb.2023.12.002_bib49","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.coi.2020.05.001","article-title":"Emerging technologies for systems vaccinology - multi- omics integration and single-cell (epi)genomic profiling","volume":"65","author":"Wimmers","year":"2020","journal-title":"Curr Opin Immunol"},{"issue":"6","key":"10.1016\/j.ijtb.2023.12.002_bib50","first-page":"877","article-title":"Community trials of BCG vaccination","volume":"77","author":"Palmer","year":"1958","journal-title":"Am Rev Tuberc Pulm Dis"},{"key":"10.1016\/j.ijtb.2023.12.002_bib51","series-title":"BCG Vaccine and Tuberculosis Vaccines","author":"Powell","year":"2004"},{"issue":"3","key":"10.1016\/j.ijtb.2023.12.002_bib52","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00281-020-00794-0","article-title":"Towards new TB vaccines","volume":"42","author":"Brazier","year":"2020","journal-title":"Semin Immunopathol"},{"issue":"4","key":"10.1016\/j.ijtb.2023.12.002_bib53","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1002\/jps.21523","article-title":"Vaccine adjuvants: current challenges and future approaches","volume":"98","author":"Wilson-Welder","year":"2009","journal-title":"J Pharmaceut Sci"},{"issue":"5","key":"10.1016\/j.ijtb.2023.12.002_bib54","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1183\/09031936.00120908","article-title":"LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement","volume":"33","author":"Mack","year":"2009","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.ijtb.2023.12.002_bib55","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1183\/09031936.00188313","article-title":"Management of patients with multidrug-resistant\/extensively drug- resistant tuberculosis in Europe: a TBNET consensus statement","volume":"44","author":"Lange","year":"2014","journal-title":"Eur Respir J"},{"issue":"1\u20132","key":"10.1016\/j.ijtb.2023.12.002_bib56","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0168-1656(00)00310-2","article-title":"Improved protection against lung colonization by Actinobacillus pleuropneumoniae ghosts: characterization of a genetically inactivated vaccine","volume":"83","author":"Huter","year":"2000","journal-title":"J Biotechnol"},{"issue":"2","key":"10.1016\/j.ijtb.2023.12.002_bib57","doi-asserted-by":"crossref","first-page":"145","DOI":"10.7774\/cevr.2015.4.2.145","article-title":"Application of radiation technology in vaccines development","volume":"4","author":"Seo","year":"2015","journal-title":"Clinical and experimental vaccine research"},{"issue":"5","key":"10.1016\/j.ijtb.2023.12.002_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010818","article-title":"Preferential amplification of CD8 effector-T cells after transcutaneous application of an inactivated influenza vaccine: a randomized phase I trial","volume":"5","author":"Combadi\u00e8re","year":"2010","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.ijtb.2023.12.002_bib59","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/infdis\/jiw228","article-title":"Vaccination against tuberculosis with whole-cell mycobacterial vaccines","volume":"214","author":"Scriba","year":"2016","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.ijtb.2023.12.002_bib60","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/joim.12212","article-title":"Recent advances towards tuberculosis control: vaccines and biomarkers","volume":"275","author":"Weiner","year":"2014","journal-title":"J Intern Med"},{"key":"10.1016\/j.ijtb.2023.12.002_bib61","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ijid.2016.10.018","article-title":"Novel approaches to tuberculosis vaccine development","volume":"56","author":"Kaufmann","year":"2017","journal-title":"Int J Infect Dis"},{"issue":"1","key":"10.1016\/j.ijtb.2023.12.002_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines8010067","article-title":"RNA sensing of Mycobacterium tuberculosis and its impact on TB vaccination strategies","volume":"8","author":"Burkert","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.ijtb.2023.12.002_bib63","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3389\/fimmu.2018.00121","article-title":"Next-generation vaccines based on bacille calmette-gu\u00e9rin","volume":"9","author":"Nieuwenhuizen","year":"2018","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.ijtb.2023.12.002_bib64","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.copbio.2012.03.007","article-title":"Recombinant live vaccine candidates against tuberculosis","volume":"23","author":"Kaufmann","year":"2012","journal-title":"Curr Opin Biotechnol"},{"issue":"19","key":"10.1016\/j.ijtb.2023.12.002_bib65","doi-asserted-by":"crossref","first-page":"9250","DOI":"10.3390\/app11199250","article-title":"Tuberculosis vaccines: an update of recent and ongoing clinical trials","volume":"11","author":"Saramago","year":"2021","journal-title":"Appl Sci"},{"key":"10.1016\/j.ijtb.2023.12.002_bib66","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/978-1-0716-1884-4_20","article-title":"An update on tuberculosis vaccines","volume":"2410","author":"Gopalaswamy","year":"2022","journal-title":"Methods Mol Biol"},{"issue":"1","key":"10.1016\/j.ijtb.2023.12.002_bib67","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/s41598-017-01501-0","article-title":"The role of hydrophobicity in tuberculosis evolution and pathogenicity","volume":"7","author":"Jankute","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijtb.2023.12.002_bib68","series-title":"Subunit Vaccine Delivery","first-page":"15","article-title":"Classification of vaccines","author":"Kallerup","year":"2015"},{"issue":"7","key":"10.1016\/j.ijtb.2023.12.002_bib69","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1080\/21645515.2018.1458806","article-title":"The current status, challenges, and future developments of new tuberculosis vaccines","volume":"14","author":"Gong","year":"2018","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.ijtb.2023.12.002_bib70","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.3389\/fimmu.2017.01803","article-title":"MTBVAC: attenuating the human pathogen of tuberculosis (TB) toward a promising vaccine against the TB epidemic","volume":"8","author":"Gonzalo-Asensio","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijtb.2023.12.002_bib71","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.3389\/fimmu.2018.01919","article-title":"Recent developments in recombinant protein-based dengue vaccines","volume":"9","author":"Tripathi","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijtb.2023.12.002_bib72","series-title":"PROSPECTS FOR VACCINATION AGAINST TB","author":"Okoroafor","year":"2023"},{"key":"10.1016\/j.ijtb.2023.12.002_bib73","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.tube.2018.07.003","article-title":"In vivo electroporation of a codon-optimized BERopt DNA vaccine protects mice from pathogenic Mycobacterium tuberculosis aerosol challenge","volume":"113","author":"Tang","year":"2018","journal-title":"Tuberculosis"},{"key":"10.1016\/j.ijtb.2023.12.002_bib74","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/978-1-4939-3387-7_3","article-title":"Principles of vaccination","volume":"1403","author":"Zepp","year":"2016","journal-title":"Methods Mol Biol"},{"issue":"1","key":"10.1016\/j.ijtb.2023.12.002_bib75","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.biori.2017.10.001","article-title":"The development of veterinary vaccines: a review of traditional methods and modern biotechnology approaches","volume":"1","author":"Jorge","year":"2017","journal-title":"Biotechnology Research and Innovation"},{"issue":"7","key":"10.1016\/j.ijtb.2023.12.002_bib76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021942","article-title":"Influenza H5 hemagglutinin DNA primes the antibody response elicited by the live attenuated influenza A\/Vietnam\/1203\/2004 vaccine in ferrets","volume":"6","author":"Suguitan","year":"2011","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ijtb.2023.12.002_bib77","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00430-011-0188-z","article-title":"A DNA vaccine expressing CFP21 and MPT64 fusion protein enhances BCG-induced protective immunity against Mycobacterium tuberculosis infection in mice","volume":"200","author":"Wang","year":"2011","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.ijtb.2023.12.002_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117594","article-title":"Tuberculosis vaccine: a journey from BCG to present","volume":"252","author":"Fatima","year":"2020","journal-title":"Life Sci"},{"issue":"5","key":"10.1016\/j.ijtb.2023.12.002_bib79","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.tube.2015.05.017","article-title":"Tuberculosis: a disease without boundaries","volume":"95","author":"Fogel","year":"2015","journal-title":"Tuberculosis"},{"issue":"1","key":"10.1016\/j.ijtb.2023.12.002_bib80","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.chom.2018.06.004","article-title":"Mechanisms of m. tuberculosis immune evasion as challenges to TB vaccine design","volume":"24","author":"Ernst","year":"2018","journal-title":"Cell Host Microbe"}],"container-title":["Indian Journal of Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019570723002196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019570723002196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T11:39:59Z","timestamp":1726313999000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0019570723002196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":88,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S0019570723002196"],"URL":"https:\/\/doi.org\/10.1016\/j.ijtb.2023.12.002","relation":{},"ISSN":["0019-5707"],"issn-type":[{"value":"0019-5707","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tuberculosis vaccine - A timely analysis of the drawbacks for the development of novel vaccines","name":"articletitle","label":"Article Title"},{"value":"Indian Journal of Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijtb.2023.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V. on behalf of Tuberculosis Association of India.","name":"copyright","label":"Copyright"}]}}